跳至主要内容
临床试验/NCT00819273
NCT00819273已完成不适用

Investigation Into the CorrelAtion of pLasma Hs-CRP Concentrations and cardiovascuLar rISk in Korean populaTiOn

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,700 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,700
试验地点
1
主要终点
Evaluate hs-CRP levels according to risk categories by the NCEP ATP III.

研究概览

简要总结

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with at least one clinic visit record within the last 12 months from the date of data entry.
  • Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry.

排除标准

  • Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement
  • Active inflammatory diseases documented during the period of CRP measurement
  • Subjects taking immunosuppressants
  • Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease

结局指标

主要结局

Evaluate hs-CRP levels according to risk categories by the NCEP ATP III.

时间窗: Within the last 12 months from the date of data entry.

次要结局

  • Evaluate a relationship between hs-CRP and each CHD CVD risk factor including LDL-C.(Within the last 12 months from the date of data entry.)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验